Dr. Reddy’s issued a voluntary recall of six lots of sapropterin dihydrochloride powder used to treat phenylketonuria (PKU) due to potential potency issues following internal testing and customer ...
Dr. Reddy’s Laboratories (NYSE:RDY) disclosed in a filing that it has bought a 6.46% stake in Edity Therapeutics. According to an SEC filing, the Indian drugmaker bought approximately 1M preferred A-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback